GridAI Technologies (GRDX) Profit After Tax (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Profit After Tax came in at -$3.3 million in Q4 2025, up 73.4% YoY from -$1.9 million in Q4 2024, and down 241.88% on a QoQ basis from -$970856.0 in Q3 2025.
GridAI Technologies (GRDX) Profit After Tax (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Profit After Tax data on file, last reported at -$3.3 million in Q4 2025.
- Quarterly Profit After Tax rose 73.4% year-over-year to -$3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.2 million (up 73.37% YoY) and the FY2025 annual result came in at -$6.7 million, up 63.23% from the prior year.
- Profit After Tax fell to -$3.3 million in Q4 2025, from -$970856.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $4.4 million in Q3 2022 to a low of -$30.4 million in Q3 2021.
- A 5-year average of -$5.9 million and a median of -$4.1 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax surged 114.33% — and 2025, when it slumped 553.3%.
- Tracing GRDX's Profit After Tax over 5 years: stood at -$11.0 million in 2021, then jumped by 63.82% to -$4.0 million in 2022, then declined by 2.88% to -$4.1 million in 2023, then sank by 204.3% to -$12.5 million in 2024, then surged by 73.4% to -$3.3 million in 2025.
- The last three Profit After Tax figures came in at -$3.3 million (Q4 2025), -$970856.0 (Q3 2025), and -$674931.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | -3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.32 Mn |
| Sep 30, 2025 | -970,856.00 |
| Jun 30, 2025 | -674,931.00 |
| Mar 31, 2025 | -1.26 Mn |
| Dec 31, 2024 | -12.48 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -8.81 Mn |
| Mar 31, 2024 | -192,808.00 |
| Dec 31, 2023 | -4.10 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -4.07 Mn |
| Dec 31, 2022 | -3.99 Mn |
| Sep 30, 2022 | 4.36 Mn |
| Jun 30, 2022 | -5.55 Mn |
| Mar 31, 2022 | -9.63 Mn |
| Dec 31, 2021 | -11.02 Mn |
| Sep 30, 2021 | -30.40 Mn |
| Jun 30, 2021 | -9.28 Mn |
| Mar 31, 2021 | -7.82 Mn |